
Yahoo · 29 de oct de 2026
For questions about this article or underlying research, email help@trefis.com.
CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Últimos 234 días · 12/11/25 — 29/10/26
+37.71%
Precio
$ 138.425
Var. %
+0,22%
Volumen operado
36
Precio CAH
US$ 250,95
Teórico (precio / ratio)
CAH ÷ 3
US$ 83,65
Yield y fechas del subyacente vía Yahoo Finance. Ver calendario de dividendos.
Yield (USD)
0,8 %
Frecuencia (estimada)
Trim.
Próxima ex-date
sin fecha
Próximo pago
sin fecha
Cobro estimado (anual)
Dividendo anual USD ÷ ratio 3
USD 0,69
Sí, existe el CEDEAR de CAH (Cardinal Health Inc) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es CAH.
El ticker del CEDEAR de Cardinal Health Inc en Argentina es CAH. La acción subyacente cotiza en NYSE con el símbolo CAH.
El CEDEAR CAH tiene un ratio de 3:1. Eso significa que 3 CEDEARs equivalen a 1 acción de CAH.
El CEDEAR CAH cotiza hoy a $ 138.425 en pesos argentinos, con una variación diaria de +0,22%.
Otros CEDEARs de Salud.

Yahoo · 29 de oct de 2026
For questions about this article or underlying research, email help@trefis.com.

Yahoo · 29 de oct de 2026
West Pharmaceutical (WST) delivered earnings and revenue surprises of +22.02% and +5.88%, respectively, for the quarter ended September 2026. Do the numbers hol…

Yahoo · 27 de oct de 2026
Cardinal Health (CAH) reached $246.45 at the closing of the latest trading day, reflecting a -2.02% change compared to its last close.
Precio de cierre en pesos argentinos. Fuente: data912.
Cotización
US$ 87,00
vs teórico
+4%
Cotización MEP implícita
$ 1.591,09
Cotización
—
vs teórico
—
Cotización Cable implícita
—
La acción subyacente CAH (Cardinal Health Inc) cotiza a US$ 250,95 en su mercado de origen (NYSE).
El precio teórico del CEDEAR CAH se calcula dividiendo el precio de CAH por el ratio (3). Hoy resulta en US$ 83,65.
En BYMA podés operar CAH en pesos, CAHD en dólar MEP y CAHC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR CAH en pesos argentinos, con datos de data912.

Yahoo · 27 de oct de 2026
Dow Jones biotech giant Amgen stock is trying to break out past a new buy point ahead of the firm's Q3 earnings report.

Yahoo · 27 de oct de 2026
Amgen's 9.9% revenue growth outpaces Novo Nordisk, but a 33.1% net margin and lower valuation multiples tell a different profitability story.

Yahoo · 24 de oct de 2026
Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial re…
Noticias vía Finnhub